Viatem is a University of Birmingham Spinout company working to exploit the therapeutic potential of PEPITEM, a novel peptide, discovered by Prof. Ed Rainger. PEPITEM controls inflammation by regulating T-Cell migration and is compromised in a range of important chronic inflammatory diseases.
Employees
Looking for a particular Viatem Employee?
Viatem's financial review
Employees
2
Employees
Looking for a particular Viatem Employee?
Viatem's financial review
Employees
2
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly